Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO22868 | Pulsatilla dahurica | Species | Ranunculaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT442 | Individual Protein | Ferritin light chain | Equus caballus | Potency | = | 35481.3 | nM | PubChem BioAssay data set |
NPT61 | Individual Protein | Beta-glucocerebrosidase | Homo sapiens | Potency | 25118.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14125.4 | nM | PubChem BioAssay data set | ||
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 70794.6 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT8 | Individual Protein | DNA polymerase iota | Homo sapiens | Potency | 1778.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 8912.5 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 23109.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 10000 | nM | PubChem BioAssay data set | ||
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 22387.2 | nM | PubChem BioAssay data set | |
NPT11 | Individual Protein | Guanine nucleotide-binding protein G(s), subunit alpha | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 14581 | nM | PubChem BioAssay data set | ||
NPT105 | Individual Protein | Muscleblind-like protein 1 | Homo sapiens | Potency | 11220.2 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC287275 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9306 | High Similarity | NPC139839 |
0.9241 | High Similarity | NPC195202 |
0.9172 | High Similarity | NPC62536 |
0.9172 | High Similarity | NPC33265 |
0.9172 | High Similarity | NPC12200 |
0.9133 | High Similarity | NPC108456 |
0.9116 | High Similarity | NPC50728 |
0.9116 | High Similarity | NPC166753 |
0.911 | High Similarity | NPC107636 |
0.906 | High Similarity | NPC475895 |
0.9054 | High Similarity | NPC236769 |
0.9054 | High Similarity | NPC208043 |
0.9054 | High Similarity | NPC226973 |
0.9054 | High Similarity | NPC308451 |
0.9048 | High Similarity | NPC177298 |
0.9048 | High Similarity | NPC159103 |
0.9048 | High Similarity | NPC183950 |
0.9048 | High Similarity | NPC48479 |
0.9048 | High Similarity | NPC328119 |
0.9048 | High Similarity | NPC137062 |
0.9048 | High Similarity | NPC287101 |
0.9048 | High Similarity | NPC223579 |
0.9048 | High Similarity | NPC52005 |
0.9007 | High Similarity | NPC474886 |
0.8993 | High Similarity | NPC39732 |
0.8993 | High Similarity | NPC60972 |
0.8993 | High Similarity | NPC289968 |
0.8986 | High Similarity | NPC219330 |
0.8986 | High Similarity | NPC306821 |
0.898 | High Similarity | NPC261548 |
0.898 | High Similarity | NPC120464 |
0.8961 | High Similarity | NPC234004 |
0.8958 | High Similarity | NPC34245 |
0.8958 | High Similarity | NPC7439 |
0.8958 | High Similarity | NPC110067 |
0.8958 | High Similarity | NPC256555 |
0.8958 | High Similarity | NPC91492 |
0.894 | High Similarity | NPC54928 |
0.8933 | High Similarity | NPC145379 |
0.8933 | High Similarity | NPC179126 |
0.8933 | High Similarity | NPC255350 |
0.8933 | High Similarity | NPC22519 |
0.8933 | High Similarity | NPC47781 |
0.8933 | High Similarity | NPC86485 |
0.8933 | High Similarity | NPC78326 |
0.8933 | High Similarity | NPC176775 |
0.8933 | High Similarity | NPC236223 |
0.8933 | High Similarity | NPC231018 |
0.8933 | High Similarity | NPC274327 |
0.8933 | High Similarity | NPC160951 |
0.8933 | High Similarity | NPC183878 |
0.8933 | High Similarity | NPC69394 |
0.8933 | High Similarity | NPC270620 |
0.8926 | High Similarity | NPC252933 |
0.8926 | High Similarity | NPC472535 |
0.8926 | High Similarity | NPC474170 |
0.8926 | High Similarity | NPC474388 |
0.8926 | High Similarity | NPC54394 |
0.8926 | High Similarity | NPC76376 |
0.8926 | High Similarity | NPC125062 |
0.8926 | High Similarity | NPC75695 |
0.8926 | High Similarity | NPC200740 |
0.8921 | High Similarity | NPC245120 |
0.8919 | High Similarity | NPC473091 |
0.8912 | High Similarity | NPC108406 |
0.8912 | High Similarity | NPC142863 |
0.8904 | High Similarity | NPC262282 |
0.8903 | High Similarity | NPC142614 |
0.8897 | High Similarity | NPC119663 |
0.8897 | High Similarity | NPC9966 |
0.8897 | High Similarity | NPC70853 |
0.8896 | High Similarity | NPC8300 |
0.8889 | High Similarity | NPC53889 |
0.8889 | High Similarity | NPC110419 |
0.8874 | High Similarity | NPC20830 |
0.8874 | High Similarity | NPC256612 |
0.8874 | High Similarity | NPC201136 |
0.8874 | High Similarity | NPC20541 |
0.8874 | High Similarity | NPC32557 |
0.8874 | High Similarity | NPC50715 |
0.8874 | High Similarity | NPC196439 |
0.8874 | High Similarity | NPC189960 |
0.8874 | High Similarity | NPC227325 |
0.8874 | High Similarity | NPC128863 |
0.8874 | High Similarity | NPC471800 |
0.8874 | High Similarity | NPC92659 |
0.8874 | High Similarity | NPC280339 |
0.8874 | High Similarity | NPC213622 |
0.8874 | High Similarity | NPC2476 |
0.8874 | High Similarity | NPC234255 |
0.8874 | High Similarity | NPC4455 |
0.8874 | High Similarity | NPC146165 |
0.8874 | High Similarity | NPC138360 |
0.8874 | High Similarity | NPC167815 |
0.8874 | High Similarity | NPC183597 |
0.8874 | High Similarity | NPC163780 |
0.8867 | High Similarity | NPC275836 |
0.8867 | High Similarity | NPC279989 |
0.8867 | High Similarity | NPC187498 |
0.8867 | High Similarity | NPC55205 |
0.8867 | High Similarity | NPC301123 |
0.8867 | High Similarity | NPC241498 |
0.8867 | High Similarity | NPC82325 |
0.8867 | High Similarity | NPC57030 |
0.8867 | High Similarity | NPC199773 |
0.8867 | High Similarity | NPC162313 |
0.8867 | High Similarity | NPC71334 |
0.8867 | High Similarity | NPC222830 |
0.8867 | High Similarity | NPC188203 |
0.8867 | High Similarity | NPC257648 |
0.8867 | High Similarity | NPC120163 |
0.8867 | High Similarity | NPC156222 |
0.8867 | High Similarity | NPC83508 |
0.8867 | High Similarity | NPC100887 |
0.8867 | High Similarity | NPC301323 |
0.8867 | High Similarity | NPC275722 |
0.8867 | High Similarity | NPC472912 |
0.8867 | High Similarity | NPC212678 |
0.8867 | High Similarity | NPC471982 |
0.8867 | High Similarity | NPC131624 |
0.8867 | High Similarity | NPC293183 |
0.8867 | High Similarity | NPC256283 |
0.8867 | High Similarity | NPC239128 |
0.8867 | High Similarity | NPC25270 |
0.8867 | High Similarity | NPC477231 |
0.8867 | High Similarity | NPC144162 |
0.8867 | High Similarity | NPC198826 |
0.8859 | High Similarity | NPC177839 |
0.8859 | High Similarity | NPC338131 |
0.8844 | High Similarity | NPC12377 |
0.8844 | High Similarity | NPC476347 |
0.8836 | High Similarity | NPC113089 |
0.8836 | High Similarity | NPC95123 |
0.8836 | High Similarity | NPC66404 |
0.8836 | High Similarity | NPC207732 |
0.8828 | High Similarity | NPC29536 |
0.8828 | High Similarity | NPC312256 |
0.8824 | High Similarity | NPC168616 |
0.8824 | High Similarity | NPC238381 |
0.8824 | High Similarity | NPC87317 |
0.8824 | High Similarity | NPC83763 |
0.8819 | High Similarity | NPC183642 |
0.8819 | High Similarity | NPC170812 |
0.8819 | High Similarity | NPC310370 |
0.8816 | High Similarity | NPC49824 |
0.8816 | High Similarity | NPC265511 |
0.8816 | High Similarity | NPC472455 |
0.8816 | High Similarity | NPC178854 |
0.8808 | High Similarity | NPC58382 |
0.8808 | High Similarity | NPC18727 |
0.8808 | High Similarity | NPC186507 |
0.8808 | High Similarity | NPC276409 |
0.8808 | High Similarity | NPC162351 |
0.8808 | High Similarity | NPC472915 |
0.8808 | High Similarity | NPC246204 |
0.8808 | High Similarity | NPC280937 |
0.8808 | High Similarity | NPC250822 |
0.8808 | High Similarity | NPC75279 |
0.8803 | High Similarity | NPC286843 |
0.88 | High Similarity | NPC50403 |
0.88 | High Similarity | NPC117579 |
0.88 | High Similarity | NPC28274 |
0.88 | High Similarity | NPC31363 |
0.88 | High Similarity | NPC133953 |
0.8794 | High Similarity | NPC111635 |
0.8794 | High Similarity | NPC92830 |
0.8792 | High Similarity | NPC474648 |
0.8792 | High Similarity | NPC87125 |
0.8792 | High Similarity | NPC270465 |
0.8786 | High Similarity | NPC307289 |
0.8784 | High Similarity | NPC476348 |
0.8784 | High Similarity | NPC168803 |
0.8784 | High Similarity | NPC187398 |
0.8782 | High Similarity | NPC85057 |
0.8782 | High Similarity | NPC130920 |
0.8776 | High Similarity | NPC134621 |
0.8776 | High Similarity | NPC136278 |
0.8776 | High Similarity | NPC471590 |
0.8776 | High Similarity | NPC157133 |
0.8774 | High Similarity | NPC471745 |
0.8774 | High Similarity | NPC476372 |
0.8774 | High Similarity | NPC476371 |
0.8767 | High Similarity | NPC134975 |
0.8766 | High Similarity | NPC292415 |
0.8766 | High Similarity | NPC24164 |
0.8759 | High Similarity | NPC472335 |
0.8759 | High Similarity | NPC472332 |
0.8758 | High Similarity | NPC224137 |
0.8758 | High Similarity | NPC160512 |
0.8758 | High Similarity | NPC470402 |
0.8758 | High Similarity | NPC183851 |
0.8758 | High Similarity | NPC63454 |
0.8758 | High Similarity | NPC75215 |
0.8758 | High Similarity | NPC203891 |
0.8758 | High Similarity | NPC68324 |
0.8758 | High Similarity | NPC156818 |
0.8758 | High Similarity | NPC38779 |
0.8758 | High Similarity | NPC183 |
0.8758 | High Similarity | NPC284820 |
0.8758 | High Similarity | NPC93376 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC287275 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8933 | High Similarity | NPD2801 | Approved |
0.8874 | High Similarity | NPD3817 | Phase 2 |
0.8742 | High Similarity | NPD1934 | Approved |
0.8707 | High Similarity | NPD1511 | Approved |
0.8693 | High Similarity | NPD4868 | Clinical (unspecified phase) |
0.8643 | High Similarity | NPD6859 | Clinical (unspecified phase) |
0.8591 | High Similarity | NPD1512 | Approved |
0.8571 | High Similarity | NPD3882 | Suspended |
0.8562 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.85 | High Similarity | NPD5844 | Phase 1 |
0.8456 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.8442 | Intermediate Similarity | NPD1465 | Phase 2 |
0.8418 | Intermediate Similarity | NPD6232 | Discontinued |
0.84 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8385 | Intermediate Similarity | NPD7054 | Approved |
0.8378 | Intermediate Similarity | NPD3750 | Approved |
0.8367 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD7472 | Approved |
0.8333 | Intermediate Similarity | NPD6799 | Approved |
0.8323 | Intermediate Similarity | NPD3818 | Discontinued |
0.8313 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8313 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8313 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8293 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8289 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.828 | Intermediate Similarity | NPD7075 | Discontinued |
0.8261 | Intermediate Similarity | NPD422 | Phase 1 |
0.8261 | Intermediate Similarity | NPD7473 | Discontinued |
0.8239 | Intermediate Similarity | NPD7199 | Phase 2 |
0.8221 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8205 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8205 | Intermediate Similarity | NPD7819 | Suspended |
0.8182 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8176 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8176 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8171 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8163 | Intermediate Similarity | NPD1510 | Phase 2 |
0.8156 | Intermediate Similarity | NPD2797 | Approved |
0.8141 | Intermediate Similarity | NPD6801 | Discontinued |
0.8137 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.8125 | Intermediate Similarity | NPD3268 | Approved |
0.8121 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8121 | Intermediate Similarity | NPD7251 | Discontinued |
0.8117 | Intermediate Similarity | NPD1653 | Approved |
0.8113 | Intermediate Similarity | NPD919 | Approved |
0.8112 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.8108 | Intermediate Similarity | NPD2796 | Approved |
0.8085 | Intermediate Similarity | NPD3225 | Approved |
0.8082 | Intermediate Similarity | NPD447 | Suspended |
0.8082 | Intermediate Similarity | NPD230 | Phase 1 |
0.8077 | Intermediate Similarity | NPD7411 | Suspended |
0.8067 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.8061 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.805 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.8042 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.8041 | Intermediate Similarity | NPD3748 | Approved |
0.8039 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.8014 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.8014 | Intermediate Similarity | NPD1240 | Approved |
0.8014 | Intermediate Similarity | NPD1613 | Approved |
0.8013 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8013 | Intermediate Similarity | NPD6398 | Clinical (unspecified phase) |
0.8013 | Intermediate Similarity | NPD4628 | Phase 3 |
0.8013 | Intermediate Similarity | NPD6599 | Discontinued |
0.7987 | Intermediate Similarity | NPD1551 | Phase 2 |
0.795 | Intermediate Similarity | NPD5494 | Approved |
0.7943 | Intermediate Similarity | NPD1608 | Approved |
0.7935 | Intermediate Similarity | NPD5403 | Approved |
0.7931 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7925 | Intermediate Similarity | NPD5402 | Approved |
0.7911 | Intermediate Similarity | NPD37 | Approved |
0.7905 | Intermediate Similarity | NPD1607 | Approved |
0.7888 | Intermediate Similarity | NPD6234 | Discontinued |
0.7875 | Intermediate Similarity | NPD4966 | Approved |
0.7875 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7875 | Intermediate Similarity | NPD4965 | Approved |
0.7875 | Intermediate Similarity | NPD7768 | Phase 2 |
0.7867 | Intermediate Similarity | NPD6099 | Approved |
0.7867 | Intermediate Similarity | NPD2935 | Discontinued |
0.7867 | Intermediate Similarity | NPD6100 | Approved |
0.7843 | Intermediate Similarity | NPD6190 | Approved |
0.7842 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7838 | Intermediate Similarity | NPD1933 | Approved |
0.7826 | Intermediate Similarity | NPD3749 | Approved |
0.7812 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7806 | Intermediate Similarity | NPD5401 | Approved |
0.78 | Intermediate Similarity | NPD4308 | Phase 3 |
0.78 | Intermediate Similarity | NPD7033 | Discontinued |
0.7778 | Intermediate Similarity | NPD3267 | Approved |
0.7778 | Intermediate Similarity | NPD1203 | Approved |
0.7778 | Intermediate Similarity | NPD3266 | Approved |
0.7762 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7758 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.7755 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7755 | Intermediate Similarity | NPD6798 | Discontinued |
0.774 | Intermediate Similarity | NPD4908 | Phase 1 |
0.773 | Intermediate Similarity | NPD17 | Approved |
0.7725 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7718 | Intermediate Similarity | NPD5124 | Phase 1 |
0.7718 | Intermediate Similarity | NPD5123 | Clinical (unspecified phase) |
0.7712 | Intermediate Similarity | NPD1652 | Phase 2 |
0.7712 | Intermediate Similarity | NPD1243 | Approved |
0.7697 | Intermediate Similarity | NPD3926 | Phase 2 |
0.7692 | Intermediate Similarity | NPD2533 | Approved |
0.7692 | Intermediate Similarity | NPD2534 | Approved |
0.7692 | Intermediate Similarity | NPD2532 | Approved |
0.7671 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7662 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7651 | Intermediate Similarity | NPD943 | Approved |
0.7635 | Intermediate Similarity | NPD4907 | Clinical (unspecified phase) |
0.7622 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7619 | Intermediate Similarity | NPD6832 | Phase 2 |
0.7607 | Intermediate Similarity | NPD6971 | Discontinued |
0.76 | Intermediate Similarity | NPD6355 | Discontinued |
0.7595 | Intermediate Similarity | NPD920 | Approved |
0.759 | Intermediate Similarity | NPD5242 | Approved |
0.7588 | Intermediate Similarity | NPD6559 | Discontinued |
0.7584 | Intermediate Similarity | NPD6233 | Phase 2 |
0.7576 | Intermediate Similarity | NPD1247 | Approved |
0.7576 | Intermediate Similarity | NPD6959 | Discontinued |
0.7569 | Intermediate Similarity | NPD9717 | Approved |
0.7564 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.756 | Intermediate Similarity | NPD7228 | Approved |
0.7551 | Intermediate Similarity | NPD9494 | Approved |
0.7548 | Intermediate Similarity | NPD4109 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD4110 | Phase 3 |
0.7544 | Intermediate Similarity | NPD7549 | Discontinued |
0.7533 | Intermediate Similarity | NPD4060 | Phase 1 |
0.7533 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7532 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.753 | Intermediate Similarity | NPD7229 | Phase 3 |
0.7518 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7517 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7517 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7516 | Intermediate Similarity | NPD4357 | Discontinued |
0.7516 | Intermediate Similarity | NPD6386 | Approved |
0.7516 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD6385 | Approved |
0.7514 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD3226 | Approved |
0.75 | Intermediate Similarity | NPD1008 | Clinical (unspecified phase) |
0.7485 | Intermediate Similarity | NPD4288 | Approved |
0.7485 | Intermediate Similarity | NPD5353 | Approved |
0.7485 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7483 | Intermediate Similarity | NPD1778 | Approved |
0.7483 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.747 | Intermediate Similarity | NPD8127 | Discontinued |
0.7468 | Intermediate Similarity | NPD3688 | Clinical (unspecified phase) |
0.7468 | Intermediate Similarity | NPD3146 | Approved |
0.7468 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7465 | Intermediate Similarity | NPD9545 | Approved |
0.7451 | Intermediate Similarity | NPD2799 | Discontinued |
0.745 | Intermediate Similarity | NPD7095 | Approved |
0.745 | Intermediate Similarity | NPD4625 | Phase 3 |
0.7448 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7448 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7448 | Intermediate Similarity | NPD1481 | Phase 2 |
0.7427 | Intermediate Similarity | NPD5953 | Discontinued |
0.7413 | Intermediate Similarity | NPD9268 | Approved |
0.74 | Intermediate Similarity | NPD411 | Approved |
0.74 | Intermediate Similarity | NPD2313 | Discontinued |
0.7397 | Intermediate Similarity | NPD4749 | Approved |
0.7384 | Intermediate Similarity | NPD7038 | Approved |
0.7384 | Intermediate Similarity | NPD7039 | Approved |
0.7379 | Intermediate Similarity | NPD1535 | Discovery |
0.7372 | Intermediate Similarity | NPD2800 | Approved |
0.7368 | Intermediate Similarity | NPD4340 | Discontinued |
0.7355 | Intermediate Similarity | NPD7266 | Discontinued |
0.7353 | Intermediate Similarity | NPD3751 | Discontinued |
0.7351 | Intermediate Similarity | NPD4062 | Phase 3 |
0.7343 | Intermediate Similarity | NPD1894 | Discontinued |
0.7321 | Intermediate Similarity | NPD3787 | Discontinued |
0.731 | Intermediate Similarity | NPD3496 | Discontinued |
0.731 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7288 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD5535 | Approved |
0.7285 | Intermediate Similarity | NPD3764 | Approved |
0.7284 | Intermediate Similarity | NPD7458 | Discontinued |
0.7284 | Intermediate Similarity | NPD5808 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD2346 | Discontinued |
0.7244 | Intermediate Similarity | NPD2344 | Approved |
0.7241 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7234 | Intermediate Similarity | NPD5283 | Phase 1 |
0.723 | Intermediate Similarity | NPD1283 | Approved |
0.7214 | Intermediate Similarity | NPD228 | Approved |
0.7213 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7212 | Intermediate Similarity | NPD8455 | Phase 2 |
0.7208 | Intermediate Similarity | NPD6651 | Approved |
0.7205 | Intermediate Similarity | NPD6273 | Approved |
0.72 | Intermediate Similarity | NPD2861 | Phase 2 |
0.7184 | Intermediate Similarity | NPD7240 | Approved |
0.7179 | Intermediate Similarity | NPD4476 | Approved |
0.7179 | Intermediate Similarity | NPD4477 | Approved |
0.7171 | Intermediate Similarity | NPD6410 | Clinical (unspecified phase) |
0.717 | Intermediate Similarity | NPD2354 | Approved |
0.7159 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7152 | Intermediate Similarity | NPD2614 | Approved |
0.7143 | Intermediate Similarity | NPD8090 | Clinical (unspecified phase) |
0.7134 | Intermediate Similarity | NPD3540 | Phase 1 |
PubChem CID   | 5393158 |
ChEMBL   | CHEMBL1528457 |
ZINC   |
Molecular Weight:   | 312.10 |
ALogP:   | 0.0636 |
MLogP:   | 2.89 |
XLogP:   | 3 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 64.99 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 1 |
# Rings:   | 3 |
# Heavy Atoms:   | 23 |